In general, individuals with lower stage BCC lesions experience a better prognosis than those with more advanced disease.
STAGE 0
Cancer is found only in the original tumor in the skin. It is only in the epidermis and has not spread to the dermis. Stage 0 is also called carcinoma in situ.
Stage I
The tumor is 2 centimeters wide or smaller, about 4/5 of an inch across .It may have spread into the dermis. It has not spread to nearby lymph nodes, muscle, cartilage, bone or organs, and has one or fewer high-risk features.
Stage II
The cancer is larger than 2 centimeters across, and has not spread to areas below the skin, such as into muscle, bone, cartilage, or lymph nodes, but only those near the original tumor. It has not spread to distant organs, and has 2 or more high-risk features.
Stage III
The cancer has spread to areas below the skin, such as into muscle, bone, cartilage, or lymph nodes, but only those near the original tumor. It has not spread to distant organs.
Stage IV
The cancer can be any size and has spread (metastasized) to 1 or more lymph nodes which are larger than 3 cm and may have spread to bones or other organs in the body.
Estimate Survival Brain Metastases Tool
Brain metastases are a common problem, with incidence estimates ranging from 100,000 to 300,000 patients per year. The Melanoma – Graded Prognostic Assessment (GPA) is a diagnosis-specific prognostic index for patients with brain metastases. Additional factors, including BRAF status, have been found to be prognostic. Those factors, weighted by significance, have been incorporated into the new Melanoma-molGPA. The GPA will help patients and their doctors select appropriate treatment and is also used for the arrangement of clinical trials.
Please note this tool is used as an estimation guide and does not replace the advice or opinion of your health care specialist.